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Abstract: Series of novel peptide-bridged bis-phenanthridine derivatives as well as 
corresponding monomers were prepared by solid phase peptide synthesis, which allowed easy 
and fast tuning of compound properties. Interactions of new derivatives with double stranded 
DNA were strongly structure-dependent, among which the most interesting is bis-
phenanthridine derivative forming intramolecular excimer, with specific fluorescence band 
sensitive to the pH as well as on the interactions with ds-DNA. Moreover, at variance to 
commonly high cytotoxic effects of phenanthridine derivatives, here studied monomeric as 
well as bis-phenanthridine derivatives exhibited negligible antiproliferative activity on a panel 
of human cell lines, which makes them promising lead compounds for development of new 
spectrophotometric markers. 
 
1. Introduction 
Very recently, even thoroughly studied molecules as classical DNA/RNA intercalator and 
marker ethidium bromide had to be re-evaluated, since it became obvious that mechanisms of 
non-covalent interactions between small molecule and DNA/RNA are not completely 
understood.[1-3] In addition, it was shown that the chemical modulation of the ethidium 
substituents is a profitable option to tune the nucleic acid recognition properties of 
phenanthridine dyes.[4] Very recent reports about numerous applications point toward 
versatility of the phenanthridine core,[5-9] including even intriguing biological activity.[10] A 
huge number of bis-phenanthridine derivatives were prepared with the aim of not only 
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enhanced affinity due to the bis-intercalation into DNA/RNA but also with the idea of 
introducing selectivity.[11] Moreover, some bis-phenanthridine compounds have shown at the 
time the highest binding constants for nucleotides but not selectivity among studied 
nucleobases.[12] Our recent results have pointed out that selectivity of bis-phenanthridine 
derivatives toward various DNA/RNA sequences could be controlled by the steric 
effects[13,14] or by electrostatic interactions with DNA/RNA backbone and/or 
nucleobases.[15,16] However, the efforts to upgrade already promising molecules quite often 
led to longer and more complicated synthetic pathways. Therefore, the strategy of convergent 
synthesis, which will retain structural features of successful molecules but allow significantly 
easier and faster modulation of active structure, would allow fine tuning of selectivity and/or 
other tasks of a novel, small molecules to be done by reasonable time and effort investment. 
Here we present easy and fast synthesis of novel peptide-bridged bis-phenanthridine 
derivatives and corresponding monomers (Scheme 1), study of their physical and chemical 
properties in aqueous medium as well as their interactions with double stranded (ds-) DNA. 
 
Scheme 1. 
 
2. Results and Discussion 
As a synthetic route to an easily variable spacer backbone, we used solid phase peptide 
synthesis procedures [17].The most prominent advantages of proposed approach are: a) an 
easy preparation of novel amino acid-phenanthridine monomer; b) oligomerisation of 
monomers can be easily controlled by means of order, chirality of linker, distance between 
monomers; c) simple and fast preparation of new generations of compounds by modification 
of the last (oligomerisation) step.  
 
Scheme 2.  
 
Interestingly, solubility of 1-5 in water at neutral conditions (c  1  10-3 M) is 
significantly higher than solubility of previously studied bis-phenanthridines,[12,15b] most 
likely due to the influence of carboxylic groups present only in 1 - 5. 
The UV-Vis spectra of compounds 1 - 5 were pH dependent, exhibiting a one step 
change at about pKa  6, attributed to the protonation of phenanthridine heterocyclic 
nitrogen.[18-20] To compare properties of neutral and protonated form of phenanthridine, all 
further experiments were done at pH 7 and pH 5, respectively. Comparison of the UV-Vis 
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spectra revealed only minor differences between protonated (pH 5) and neutral (pH 7) form of 
compounds 1-5. A comparison of the UV-Vis spectra (Figure 1) revealed high similarity of 
spectra of 1 and 2, pointing toward negligible contribution of absorbance of glycine in 2. 
Interestingly, the molar absorbencies (Figure 1) of bis-phenanthridine derivatives 3 and 4 are 
much lower than sum of UV-Vis spectra of two monomers (1+1 in comparison to 3 and 1+2 
in comparison to 4). Such a hypochromic effect strongly suggests intramolecular aromatic 
stacking interactions between phenanthridine subunits of 3 and 4. Although the molar 
absorbance of bis-phenanthridine 5 is lower than sum of UV-Vis spectra of two monomers 
(2+2), hypochromic effect is much less pronounced in comparison to 3 and 4, pointing that 
introduction of two glycines between phenanthridine subunits significantly reduced efficiency 
of intramolecular aromatic stacking interactions. 
 
Figure 1. 
 
Compounds 1 - 5 exhibit strong fluorescence emission of phenanthridine chromophore 
(Figure 2). Fluorescence spectra of 1, 2, 4, 5 are quite similar, while spectrum of 3 is 
significantly different at both, pH 5 and 7. Most intriguingly, at pH 7 fluorescence spectrum 
of 3 is characterized by two maxima, one at  = 375 nm (agreeing well with emission maxima 
of 1, 2, 4, 5) and other maximum strongly shifted to longer wavelengths ( = +93 nm, max = 
468 nm) in respect to other studied compounds. At pH 5 two emission maxima of 3 are not 
well separated, most likely due to the protonation of phenanthridines, which affected 
intramolecular aromatic stacking interactions. However, broad maximum at about  = 440 nm 
is still significantly shifted to longer wavelengths ( = +40 nm) in respect to 1, 2, 4, 5.  
 
Figure 2. 
 
 
CD spectroscopy: All studied compounds are chiral due to the asymmetric carbon atom of 
substituted L-alanine. Turbidity of solutions of several compounds at pH 7 hampered 
collection of accurate CD spectra, while better solubility of 1 - 5 at pH 5 (due to the 
protonation of phenanthridine) allowed accurate comparison of their CD spectra (Figure 3). 
Although phenanthridine chromophore is not chiral, in compounds 1 - 5 it is closely related to 
chiral centre, therefore positive CD bands of 1 and 2 at 250 nm agree well with the maxima in 
the UV/Vis spectra of 1, 2 and consequently could be attributed to the phenanthridine. 
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Figure 3. 
 
However, CD spectra of bis-phenanthridine derivatives 4, 5 and especially 3 significantly 
differ from the CD spectra of monomers (1, 2). The CD spectra of 3 and 5 are characterized 
by negative band at about 270 nm and in addition exclusively 3 revealed significant 
hypsochromic shift of positive CD band (= -13 nm) in respect to all other compounds. 
Most intriguingly, CD spectrum of 4 is of opposite (negative) sign in respect to 1, 2, 3 and 5 
at < 240 nm and also opposite (positive) sign to 3 and 5 at  > 270 nm. The additional CD 
band of 3-5 at  > 270 nm (which monomers 1, 2 do not possess) could be attributed to the 
induced CD (ICD) effect resulting from intramolecular interactions of phenanthridine 
subunits, whereby opposite sign of CD spectrum of 4 in respect to 3 and 5 suggests different 
mutual orientation of phenanthridine subunits. 
 
Discussion of spectroscopic properties of 1-5: 
Hypochromic effect in the UV-Vis spectra suggests intramolecular aromatic stacking 
interaction in dimers (3-5). However, a specific fluorescence maximum of 3 in respect to 
other bis-phenanthridine derivatives (4, 5) could be correlated to the properties of the linker 
between phenanthridine subunits, which is in the case of  3 significantly shorter and more 
rigid if compared to linkers of 4, 5. Consequently, phenanthridine subunits of 3 could form 
highly efficient intramolecular stacking interactions, whereby mutual orientation of aromatic 
moieties is strictly controlled by rigid linker and therefore most likely one dominant form of 
stacked conformation prevails. Presumed difference of intramolecular stacked conformation 
of 3 in respect to 4 and 5 is additionally supported by pronounced differences in the 
corresponding CD spectra. Most intriguingly, it seems that electronic properties of 
intramolecularly stacked conformation of 3 are characterized by specific fluorescence 
maximum, which is strongly shifted to longer wavelengths in respect to monomers (1, 2) and 
dimers with longer and more flexible linkers (4, 5). Very similar change in fluorescence is 
well described for pyrene,[21,22] namely fluorescence of single pyrene molecule (max=378 
and 391 nm) is significantly shifted to longer wavelengths (max=450-480 nm) upon aromatic 
stacking of two or more pyrene molecules and formation of an pyrene excimer.  
  
 
 Interactions of 1-5 with ct-DNA:  
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The UV-Vis spectra of compounds 1, 2 exhibited strong hypochromic changes as well as 
pronounced batochromic shifts of the absorption maxima upon titration with ct-DNA (Figure 
4), pointing toward involvement of 1, 2 into strong - aromatic stacking interactions with 
DNA. Isosbestic points strongly suggest that both, 1 and 2, form only one dominant type of 
complex with ct-DNA. The changes of 3-5 UV-Vis spectra at  > 300 nm upon mixing with 
ct-DNA are significantly less pronounced than 1 and 2. 
 
Figure 4. 
 
Addition of ct-DNA to 1-5 at both, pH 7 and pH 5, resulted in strong quenching of their 
fluorescence (Figure 5). Processing of titration data by means of Scatchard equation [23] gave 
logKs values (Table 1). Somewhat higher affinity of all studied compounds toward ct-DNA 
was obtained at pH 5 than at pH 7, which could be attributed to additional binding 
contribution of positive charge of phenanthridine units protonated at weakly acidic conditions. 
Furthermore, dimers 3-5 revealed stronger affinity toward ct-DNA than monomers 1 and 2, 
most likely due to the simultaneous involvement of both phenanthridine subunits in binding. 
Intriguingly, titration with ct-DNA resulted in pronounced hypsochromic shift of emission 
maximum of 3 (Figure 5B,   -30 nm). The resulting fluorescence spectrum of 3/ct-DNA 
complex closely resembled to the spectra of monomers 1 and 2 bound to ct-DNA (Figure 5A). 
Such a change of emission spectrum could be attributed to the DNA-induced dissociation of 
intramolecular excimer of 3. 
 
Figure 5. 
 
Table 1. 
 
In order to get better insight into the changes of polynucleotide properties induced by binding 
of 1-5, we have chosen CD spectroscopy as a highly sensitive method toward conformational 
changes in the secondary structure of polynucleotides.[24,25] Comparison of the CD spectra 
collected at ratio r[compd]/[ct-DNA]=0.3 and the sum of corresponding CD spectra of the free ct-
DNA + free compound (Supplementary Material)Error! Bookmark not defined. revealed strong non-
additivity and actually pronounced hypochromic effect in respect to both, CD spectra of free 
DNA and free 1-5. Such a pronounced effect pointed toward significant changes in chiral 
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structures of both, DNA and studied compounds induced by complex formation.  
 
Table 2. 
 
Addition of 1-5 yielded outstandingly different stabilization effects on thermal denaturation of 
ct-DNA double helix (Table 2). Interestingly, monomer 2 significantly stronger stabilized 
DNA double helix than 1, pointing that glycine of 2 also contributed to stabilizing 
interactions. Furthermore, strongly nonlinear dependence of ΔTm values on the ratio r 
(Supplementary Material)Error! Bookmark not defined. suggested for monomer 2 saturation of 
binding sites at r = 0.3, whereby nonlinear dependence of ΔTm values on the ratio r pointed 
that binding sites of dimer 3 were already saturated at r=0.2. Since at saturation of binding 
sites the Tm values of 2 and 3 are virtually the same, dominant interaction with ct-DNA 
could be attributed to the only one phenanthridine unit, whereby other phenanthridine unit of 
3 is stacked to the outer surface of DNA, in that way lowering the density of binding sites. 
Dimers 4 and 5 yielded Tm values more than double in comparison to Tm value obtained for 
monomer 2, pointing toward simultaneous involvement of both phenanthridine subunits of 4 
and 5 in the ct-DNA stabilization. 
 
Biological Results and Discussion 
 
In general, representatives of tested compounds (1 and 4) didn’t show any growth 
inhibitory activity on the presented panel of cell lines (Table 3), which contradicts commonly 
high cytotoxic effects of phenanthridine derivatives.  
 
Table 3.  
 
 The observed lack of citotoxicity most likely could be attributed to the attached amino acid 
substituents to the phenanthridine subunits. It could be speculated that compounds, which are 
negatively charged (amino acid carboxylic residues) at common physiological conditions of 
pH=7 (pKa=6 of phenanthridine dictates protonation and positive charge at pH 5) either less 
efficiently cross cell membrane or (more likely) show diminished affinity toward cellular 
DNA, whereby the exact reason has to be determined in more detailed biological studies. 
 
 
3. Conclusions 
  Series of peptide-bridged bis-phenanthridine derivatives (3-5) and corresponding 
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monomers (1, 2) were prepared by approach based on solid phase peptide synthesis 
procedures. The advantages in respect to commonly used synthesis[11,12,15] were 
demonstrated by easy and efficient modulation of bis-phenanthridine structure starting from 
the only two building blocks (glycine and phenanthridine-L-alanine), which allowed simple 
tuning of the cavity size between phenanthridine subunits as well as intramolecular rigidity of 
compounds. Spectrophotometric studies revealed that in biologically relevant medium bis-
phenanthridine derivatives exhibit significant intramolecular interactions strongly dependent 
on the rigidity and length of the peptide linker. Moreover, to the best of our knowledge, bis-
phenanthridine 3 is the first phenanthridine derivative exhibiting specific fluorescence signal, 
which could be most likely attributed to the intramolecular excimer formation. Even more, 
that fluorescence signal of 3 showed to be sensitive on the pH of solution as well as on the 
interactions with ds-DNA. Corresponding properties of pyrene were quite extensively applied 
for several purposes[21-28] and 3 brought new features to it, possessing heterocyclic nitrogen 
prone to protonation at weakly acidic conditions (pKa  6). Furthermore, strong batochromic 
and hypochromic effects in the 1-5 UV/Vis spectra, pronounced hypochromic effects in the 
CD spectra (of both, ct-DNA and 1-5), high affinity toward ct-DNA as well as pronounced 
thermal stabilization effects strongly support the intercalation of 1-5 into ct-DNA as a 
dominant binding mode. Significantly stronger thermal stabilization effects of dimers 4 and 5 
in respect to monomer 2 point toward simultaneous involvement of both phenanthridine 
subunits of 4 and 5; whether due to the bis-intercalation or because of mono-intercalation 
accompanied by additional interactions of the non-intercalated phenanthridine subunit along 
the DNA double helix, it still remains to be determined. Moreover, at variance to the most of 
phenanthridine derivatives, preliminary studies indicated insignificant antiproliferative 
activity of 1-5 toward five tumour cell lines. Thus, studied compounds are comparatively safe 
for handling, and could be good lead compounds for development of safe phenanthridine-
based fluorescent markers, whose selectivity could be controlled by linker properties and pH 
of a solution. 
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4. Experimental  
 
Materials and Methods: 
 
Synthetic procedures and characterisation of novel compounds 1-5 is given in 
Supplementary Material.  
Calf thymus ct-DNA was purchased from Aldrich, dissolved in Na-cacodylate buffer, I 
= 0.05 M, pH=7 and additionally sonicated and ﬁltered through a 0.45 µm ﬁlter.[29] 
Polynucleotide concentration was determined spectroscopically [30] as concentration of 
phosphates. 
The electronic absorption spectra were obtained on Varian Cary 100 Bio spectrometer, 
CD spectra were collected on the Jasco J-810 spectrometer and fluorescence spectra were 
recorded on a Varian Cary Eclipse fluorimeter; all in quartz cuvettes (1 cm). The pH 
measurement was carried out using Mettler TOLEDO MP220 pHmeter calibrated with 
commercially available buffered aqueous solutions of pH standards 4.00 and 7.00. The 
measurements were performed in aqueous buffer solution (pH=7 - buffer Na cacodylate, I = 
0.05 M, pH = 5 - buffer citric acid/NaOH, I=0.03 M). Under the experimental conditions used 
buffered aqueous solutions of studied compounds were stable for more days, the absorbencies 
were proportional to concentrations of 1-5 up to c = 3  10-5 M, changes of the 1-5 UV/Vis 
spectra on the temperature increase up to 85 0C were negligible and reproducibility of UV/Vis 
spectra upon cooling back to 25 0C was excellent, indicating that studied compounds do not 
aggregate by intermolecular stacking at experimental conditions used. In fluorimetric 
titrations excitation wavelength of exc>300 nm was used to avoid inner filter effects caused 
by absorption of excitation light by added ct-DNA. The binding constant (Ks) and [bound 1-5] 
/ [DNA phosphate] ratio (n) were calculated according to the Scatchard equation by non-
linear least-square fitting,23 giving excellent correlation coefficients (>0.999) for obtained 
values for Ks and n. Thermal denaturation curves for ct-DNA and its complexes with 1-5 were 
determined as previously described by following the absorption change at 260 nm as a 
function of temperature.[29,30] The absorbance of 1-5 was subtracted from every curve, and 
the absorbance scale was normalized. Obtained Tm values are the midpoints of the transition 
curves, determined from the maximum of the first derivative or graphically by a tangent 
method. Given Tm values were calculated subtracting Tm of the free nucleic acid from Tm of 
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complex. Every Tm value here reported was the average of at least two measurements, the 
error in Tm is  0.5 °C. 
Proliferation assay. The HeLa, MiaPaCa-2, SW 620, MCF-7 and H460 cell lines were seeded 
into a series of standard 96-well microtiter plates on day 0, at 1 × 104 to 3 × 104 cells/mL, 
depending on the doubling times of the specific cell lines. Test compounds were then added in 
five, 10-fold dilutions (10-8 to 10-4 M) and incubated for a further 72 hours. Stock solutions 
were prepared in DMSO, (c = 0.04 M), while working dilutions were freshly prepared on the 
day of testing. The solvent (DMSO) was also tested for eventual inhibitory activity by 
adjusting its concentration to be the same as in working concentrations (DMSO concentration 
never exceeded 0.1%). After 72 hours of incubation the cell growth rate was evaluated by 
performing the MTT assay, as described previously.[31] 
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Tables 
 
Table 1. Binding constants (logKs)a calculated from the fluorimetric titrations of 1-5 with ct-
DNA at pH = 7.0 (buffer Na cacodylate, I = 0.05 M) and pH = 5.0 (buffer citric acid/NaOH, I 
= 0.03 M). 
  pH = 7.0 pH = 5.0 
 logKs bI/I0 logKs 
bI/I0 
1 4.5 0.1 5.4 0.10 
2 4.7 0.07 5.5 0.19 
3 c c 6.7 0.20 
4 6.0 0.08 6.9 0.08 
5 5.4 0.59 5.9 0.19 
aProcessing of titration data by means of Scatchard equation [23] gave values of ratio n[bound 
1-5]/ [ct-DNA] = 0.2 - 0.3, for easier comparison all logKs values were re-calculated for fixed 
n=0.2; bI0  - starting fluorescence intensity of 1 - 5; I – fluorescence intensity of 1-5/ct-DNA 
complex calculated by Scatchard equation. cToo small spectroscopic changes (I/I0 =0.85). 
 
 
 
Table 2.  The aTm values (°C) of ct-DNA upon addition of different ratios br of 1-5 at pH = 
5.0 (buffer citric acid/NaOH, I = 0.03 M). 
br = 0.1 0.2 0.3 
1 - - 4.0 
2 6.5 8.1 11.1 
3 8.6 11.0 11.3 
4 14.3 16.5 18.4 
5 16.0 18.8 20.2 
aError in Tm :  0.5°C; br = [compound] / [ct-DNA]. 
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Table 3. Tumour cell growth inhibition presented as IC50 values (in µM). 
Compound 
 
Cell lines 
 
HeLa MiaPaCa-2 SW 620 MCF-7 H 460 
1 >100 >100 >100 >100 >100 
4 >100 ≥100 >100 >100 >100 
a IC50; the concentration that causes 50% growth inhibition 
 
Figure legends 
 
Scheme 1. Prepared bis-phenanthridine derivatives 3-5 and corresponding monomers 1, 2. 
Scheme 2. A general procedure of applied solid phase synthesis, details are given in the 
Supporting information. 
Figure 1. The UV-Vis spectra of 1-5 at: A) pH = 7.0 (buffer Na cacodylate, I = 0.05 M); B) 
pH = 5.0 (buffer citric acid/NaOH, I = 0.03 M). 
Figure 2. The fluorescence emission spectra of 1-5 at: at: A) pH = 7.0 (buffer Na cacodylate, I 
= 0.05 M); B) pH = 5.0 (buffer citric acid/NaOH, I = 0.03 M). Experimental conditions: c(1-
5) = 2 - 6  10-6 M,  different parameters of the instrument were adjusted to give similar 
intensity of emission maxima, therefore presented fluorescence intensities cannot be directly 
compared. 
Figure 3. The CD spectra of 1-5 at pH = 5.0 (buffer citric acid/NaOH, I = 0.03 M). 
Figure 4. The UV-Vis titration of 1 (A, c = 2.0 × 10-5 M) and 2 (B, c = 2.0 × 10-5 M) with ct-
DNA (c = 0 - 6.0 × 10-4 M), pH = 7.0, buffer Na cacodylate, I = 0.05 M. At the pH = 5.0 
(buffer citric acid/NaOH, I = 0.03 M) similar results were obtained. 
Figure 5. Fluorimetric titration of 1 with ct-DNA and fitting of the experimental (■) and 
calculated (▬) data [23] (A); Fluorimetric titration of 3 with ct-DNA (B). Done at pH = 5.0, 
buffer citric acid/NaOH, I = 0.03 M, exc=320 nm, c(compound) = 2 × 10-6 M. 
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Figures and schemes 
 
Scheme 1. 
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